A research group at Cairo University (Egypt) and others conducted a clinical study. The study titled “Arabinoxylan rice bran (Biobran) suppresses the viremia level in patients with chronic HCV infection: A randomized trial” was published in the “International Journal of Immunopathology and Pharmacology”.